Belite Bio Inc - Adr share price logo

Belite Bio Inc - Adr Share Price

NASDAQ: BLTE

Small Cap

$74.37

+1.37

(+1.88%)

Live

as on

Belite Bio Inc - Adr Stock Performance

as on September 18, 2025 at 10:36 pm IST

  • Day's Low

    Day's High

    $73
    $74.25
    downward going graph

    1.84%

    Downside

    -0.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $43.7
    $86.53
    downward going graph

    41.24%

    Downside

    16.35%

    Upside

    downward going graph

Belite Bio Inc - Adr share price movements today

Previous Close
$73.00
Open
$73.16
Volume
257.3K
Day's Low - High
$73 - $74.25
52 Week Low - High
$43.7 - $86.53

Belite Bio Inc - Adr Historical Returns

1 Month Return
+ 12.39 %
3 Month Return
+ 20.94 %
1 Year Return
+ 51.11 %
3 Year Return
+ 88.1 %
5 Year Return
0 %

Belite Bio Inc - Adr Stock Fundamentals & Key Indicators

Check Belite Bio Inc - Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-1.9233

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-25.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

396900.00%

Belite Bio Inc - Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Belite Bio Inc - Adr with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.4BNANA0.00%
BUY$60.5B241.54%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Belite Bio Inc - Adr Stock including INR - Dollar returns

The Belite Bio Inc - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Belite Bio Inc - Adr investment value today

Current value as on today

₹1,58,897

Returns

₹58,897

(+58.9%)

Returns from Belite Bio Inc - Adr Stock

₹53,943 (+53.94%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Belite Bio Inc - Adr Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Belite Bio Inc - Adr. Average target price of $93.25

Belite Bio Inc - Adr Share Price Target

Get share price movements and forecasts by analysts on Belite Bio Inc - Adr.

What analysts predicted

20.25%UPSIDE

Target Price

$93.25

Current Price

$74.37

Analyzed by

11 Analysts

Target

$93.25

Belite Bio Inc - Adr target price $93.25, a slight upside of 20.25% compared to current price of $74.37. According to 11 analysts rating.

Belite Bio Inc - Adr Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-6
-6
-10
-6
-10
-10
-9
-11
-15
-17
EBITDA
-6
-6
-10
-6
-10
-
-9
-11
-15
-16
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-6
-6
-10
-6
-9
-9
-8
-10
-14
-16
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-6
-6
-10
-6
-9
-9
-8
-10
-14
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Belite Bio Inc - Adr Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-5
-9
-12
-31
-39
EBITDA
-5
-9
-12
-31
-35
Interest Expense
0
0
0
0
0
Depreciation
0
0
0
0
0
Income Before Tax
-5
-9
-12
-31
-36
Income Tax Expense
0
0
0
0
0
Net Income
-5
-9
-12
-31
-36
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Belite Bio Inc - Adr Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
0
0
0
0
0
0
0
0
-16
Operating Cash Flow
-1
-
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
Change in Cash
19
-2
-
-
-
-
-
-
-

Belite Bio Inc - Adr Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-9
-12
-31
-36
Operating Cash Flow
-7
-11
-29
-29
Investing Cash Flow
0
0
0
-110
Financing Cash Flow
0
36
75
83
Change in Cash
-8
24
46
-56

Global Institutional Holdings in Belite Bio Inc - Adr

Funds
Holdings
Alyeska Investment Group, L.P.
0.26%
State Street Corp
0.06%
Geode Capital Management, LLC
0.04%
JPMorgan Chase & Co
0.03%
Citadel Advisors Llc
0.02%

Insights on Belite Bio Inc - Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BLTE stock has moved up by 6.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 17.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 23.4%

About Belite Bio Inc - Adr

belite bio inc is a san diego based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. developed from our anti-rbp4 technology platform, our lead candidate, lbs-008, is currently in a phase i clinical trial for dry age-related macular degeneration and its juvenile form, stargardt disease. lbs-008 has received orphan drug status in the us and europe, as well as rare pediatric disease status in the us.
OrganisationBelite Bio Inc - Adr
Headquarters12750 High Bluff Drive, San Diego, CA, United States, 92130
IndustryHealthcare
CEODr. Yu-Hsin Lin M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Belite Bio Inc - Adr

Name

Title

Dr. Yu-Hsin Lin M.B.A., Ph.D.

Chairman of the Board of Directors & CEO

Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.

CFO & Director

Dr. Nathan L. Mata Ph.D.

Chief Scientific Officer

Dr. Hendrik P.N. Scholl M.A., M.D., Ph.D.

Chief Medical Officer

FAQs

What is Belite Bio Inc - Adr share price today?

Belite Bio Inc - Adr share price today is $74.37 as on . Belite Bio Inc - Adr share today touched a day high of $74.25 and a low of $73.

What is the 52 week high and 52 week low for Belite Bio Inc - Adr share?

Belite Bio Inc - Adr share touched a 52 week high of $86.53 on and a 52 week low of $43.7 on . Belite Bio Inc - Adr stock price today i.e. is trending at $74.37,which is 14.05% down from its 52 week high and 70.18% up from its 52 week low.

What is Belite Bio Inc - Adr's market capitalisation today?

Belite Bio Inc - Adr market capitalisation is $0.00T as on .

How to invest in Belite Bio Inc - Adr Stock (BLTE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Belite Bio Inc - Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Belite Bio Inc - Adr Shares that will get you 0.0202 shares as per Belite Bio Inc - Adr share price of $74.37 per share as on September 18, 2025 at 10:36 pm IST.

What is the minimum amount required to buy Belite Bio Inc - Adr Stock (BLTE) from India?

Indian investors can start investing in Belite Bio Inc - Adr (BLTE) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Belite Bio Inc - Adr stock (as per the Rupee-Dollar exchange rate as on ). Based on Belite Bio Inc - Adr share’s latest price of $74.37 as on September 18, 2025 at 10:36 pm IST, you will get 0.1345 shares of Belite Bio Inc - Adr. Learn more about fractional shares .